Status:
COMPLETED
Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The safety and efficacy of FTY720 is being evaluated in patients who receive a kidney transplant.
Eligibility Criteria
Inclusion
- Patients undergoing their first kidney transplant
- Male or female age 18 to 65 years
Exclusion
- Patients in need of second kidney transplant or multi-organ transplants.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00099801
Start Date
January 1 2005
End Date
March 1 2006
Last Update
June 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.